Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 2
2011 pubmed 8 citations

Activation of growth hormone secretagogue type 1a receptor inhibits T-type Ca2+ channel currents through pertussis toxin-sensitive novel protein kinase C pathway in mouse spermatogenic cells.

Liu. Kangyong K; Jiang. Dongsheng D; Zhang. Ting T; Tao. Jin J; Shen. Liwei L; Sun. Xiaojiang X

Key Findings

  • Ghrelin dose‑dependently inhibits T‑type Ca2+ channel currents in mouse spermatogenic cells.
  • The inhibition is blocked by D‑Lys3‑GHRP‑6, a selective GHS‑R1a antagonist, indicating the receptor mediates the effect.
  • The signaling requires a pertussis‑toxin‑sensitive, novel PKC pathway (not PKA or classical PKC).

Practical Outcomes

  • For biohackers, this hints that manipulating ghrelin or GHS‑R1a (e.g., with GHRP‑6 analogues) could affect sperm calcium signaling and potentially fertility, but the data are from mouse cells and the exact human relevance, dosing, and safety are unknown. No immediate protocol changes are recommended; further research is needed before applying this to human male reproductive health.

Summary

The study shows that the hormone ghrelin can lower the activity of a specific calcium channel (T-type) in mouse sperm cells, and this effect works through the growth hormone secretagogue receptor (GHS‑R1a) using a novel protein‑kinase‑C pathway. Blocking this receptor with a GHRP‑6‑derived antagonist stops the effect, suggesting the pathway could be part of how ghrelin influences male fertility.

Abstract

Ghrelin, a newly isolated brain-gut peptide, has been found to play important roles in the male reproduction. However, to date, the detailed mechanisms still remain unknown. In this study, we identified a novel functional role of ghrelin in modulating T-type Ca(2+) channel currents (T-currents) in mouse spermatogenic cells. We found that ghrelin inhibited T-currents in a dose-dependent manner. Ghrelin at 0.1 μM reversibly inhibited T-currents by ∼31.7%. This inhibitory effect was blocked by D-Lys3-GHRP-6, a selective growth hormone secretagogue receptor 1a (GHS-R1a) antagonist. Intracellular infusion of GDP-b-S or pretreatment of the cells with pertussis toxin (PTX) completely blocked the inhibitory effects of ghrelin. Furthermore, ghrelin responses were abolished by the phospholipase C inhibitor U73122, but not the inactive analogue U73343. The classical and novel protein kinase C antagonist chelerythrine chlorid or GF109203X abolished ghrelin responses, whereas Ro31-8820, a classical PKC antagonist or PKI 6-22, a PKA antagonist, elicited no such effects. Taken together, these results suggest that ghrelin acting through GSH-R1a inhibits T-currents via a PTX-sensitive novel PKC pathway in mouse spermatogenic cells, which could contribute to its male reproductive functions such as acrosome reactions.

Study Information

Provider

pubmed

Year

2011

Date

2011-06-15T00:00:00.000Z

DOI

10.1159/000329983

Citations

8

References

38